Additionally, in the AML and AMH groups, the RNA levels of Atrogin-1, TNFα, NF-κB, MyoD, and IGF1 changed in a dose-dependent manner (Figure 3e-g), indicating that this mixed extract contains active components that synergistically regulate gene expression related to muscle strength. The gene discussed is NFKB1; the disease is acute myeloid leukemia.